Basit öğe kaydını göster

dc.contributor.authorAlbayrak, D
dc.contributor.authorIslek, I
dc.contributor.authorKalayci, Ag
dc.contributor.authorGurses, N
dc.date.accessioned2020-06-21T11:31:52Z
dc.date.available2020-06-21T11:31:52Z
dc.date.issued1994
dc.identifier.issn0022-3476
dc.identifier.issn1097-6833
dc.identifier.urihttps://doi.org/10.1016/S0022-3476(05)82024-4
dc.identifier.urihttps://hdl.handle.net/20.500.12712/9915
dc.descriptionWOS: A1994PW57200027en_US
dc.descriptionPubMed: 7996346en_US
dc.description.abstractWe compared very high doses of methylprednisolone with intravenously administered immune globulin for treatment of acute idiopathic thrombocytopenic purpura. Fifty-seven children were randomly assigned to receive the immune globulin preparation, 0.5 gm/kg per day for 5 consecutive days (n = 19), orally administered methylprednisolone, 30 mg/kg per day for 7 days (n = 19), or orally administered methylprednisolone, 50 mg/kg per day for 7 days (n = 19), There were no differences in the response of the platelet counts among the groups, We conclude that these two therapies were equally effective; choice between them may be made according to cost and therapy-related risks.en_US
dc.language.isoengen_US
dc.publisherMosby-Elsevieren_US
dc.relation.isversionof10.1016/S0022-3476(05)82024-4en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAcute Immune Thrombocytopenic Purpura - A Comparative-Study of Very High Oral Doses of Methylprednisolone and Intravenously Administered Immune Globulinen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume125en_US
dc.identifier.issue6en_US
dc.identifier.startpage1004en_US
dc.identifier.endpage1007en_US
dc.relation.journalJournal of Pediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster